Endometriosis: An Immunologist's Perspective

Area of Science:

• Reproductive immunology
• Gynecological pathology

Background:

• Endometriosis affects 10-15% of reproductive-age women, causing inflammation, fibrosis, and pain.
• Characterized by endometrial tissue growth outside the uterus, leading to hormonal imbalances and immune dysregulation.
• Associated with infertility, autoimmunity, and ovarian cancer, highlighting its complex nature.

Purpose of the Study:

• To review the complex inflammatory and immunological aspects of endometriosis.
• To discuss the role of various immune cells and cytokines in disease pathogenesis.
• To explore current and emerging therapeutic strategies, focusing on immunomodulation.

Main Methods:

• Literature review of endometriosis pathogenesis, immunology, and treatment.
• Analysis of the roles of cytokines, metalloproteinases, and immune cells (macrophages, NK cells, T cells).
• Examination of genetic predispositions and the impact on zygote implantation and fertility.

Main Results:

• Endometriotic lesions exhibit overproduction of inflammatory mediators and extracellular vesicles.
• Specific immune cell populations (macrophages, T cells, reduced NK cells) are implicated in disease progression.
• Inflammation in endometriosis impairs zygote implantation, contributing to infertility.

Conclusions:

• Modulating the immune response is critical for endometriosis treatment.
• Anti-inflammatory and immunomodulatory therapies, including cytokine-targeting agents, show promise.
• Further research is essential to optimize treatments for endometriosis patients.